Morgan Stanley Stock Surges to Record High Despite 24.69% Drop in Volume Ranks 166th in 500M Trading Activity

Generated by AI AgentAinvest Market Brief
Wednesday, Aug 27, 2025 9:23 pm ET1min read
Aime RobotAime Summary

- Morgan Stanley’s stock hit a record high of $149.09 on August 27, 2025, despite a 24.69% drop in trading volume to $500 million.

- Q2 earnings rose 17% YoY to $2.13/share, but analysts noted mixed performance in Wealth Management and Investment Management divisions.

- Strategic moves included a $2B IntraFi debt package and the undisclosed sale of Clarity Software Solutions to mPulse, reflecting capital return priorities.

- Analyst ratings diverged, with Freedom Broker downgrading to Hold and Evercore ISI raising its target to $150, highlighting market uncertainty amid evolving dynamics.

Morgan Stanley’s stock closed at $149.09 on August 27, 2025, marking a new all-time high. The firm’s shares rose 0.28% despite a 24.69% decline in trading volume to $500 million, ranking it 166th in market activity. The stock trades at a P/E ratio of 16.6x and a 2.69% dividend yield, reflecting its appeal to income-focused investors.

Second-quarter earnings per share reached $2.13, up 17% year-over-year but down 18% from the prior quarter. Analysts highlighted strong performance in Wealth Management and Investment Management, though mixed sentiment emerged. Freedom Broker downgraded the stock to Hold with a $126 target, while

ISI raised its target to $150, maintaining an Outperform rating. Strategic moves included arranging a $2 billion debt package for IntraFi and completing the sale of Clarity Software Solutions.

Recent developments include

Capital Partners’ undisclosed sale of Clarity Software Solutions to mPulse. The firm also announced regular dividends on preferred stock series, with payments scheduled for September and October 2025. These actions underscore a focus on capital returns and strategic partnerships amid evolving market dynamics.

Here is some news for you to review: ENGO Eyewear launched its ENGO 2 smart eyewear, Healthy Extracts expanded product offerings on

, and faces a class action lawsuit over alleged financial misstatements. These updates span technology, consumer goods, and legal sectors, each with potential market implications for their respective industries.

Comments



Add a public comment...
No comments

No comments yet